Breaking News
Ad-Free Version. Upgrade your experience. Save up to 40% More details

AIG Stock Up 14% This Year, Are Its Troubles Over?

By Zacks Investment ResearchStock MarketsApr 11, 2019 08:14AM ET
AIG Stock Up 14% This Year, Are Its Troubles Over?
By Zacks Investment Research   |  Apr 11, 2019 08:14AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

American International Group, Inc. (NYSE:AIG) is in troubled waters, owing to challenges in the property and casualty markets that have dented revenues in one of its most important business — the General Insurance.

Other macro factors such as low interest rates, currency exchange rates, credit and equity market conditions as well as catastrophic events have also acted as dampeners.

These factors have hurt the company’s price performance. In 2018, the stock tanked by 34% compared with its industry’s decline of 6%.

Though the stock has staged some recovery with a gain of 14% so far this year, compared with the industry’s gain of 6%, it still pales in comparison with other companies in the same space such as Prudential (LON:PRU) financial Inc. (NYSE:PRU) , The Progressive Corporation (NYSE:PGR) gain of 21%,19%, respectively.

Certain factors nagging the company continue to exist. Thus, considering the headwinds, we believe that the stock will be under pressure in the upcoming quarters.

Factors Hurting the Stock

Top line Under Pressure: The company’s revenues have suffered over the years from declining premium due to disciplined underwriting, competitive market conditions and reduction in business stemming from numerous divestitures. This is evident from 2013 to 2018. Challenges in the property and casualty market as well as continued business dispositions will keep the top line under pressure.

Weakness in General Insurance Segment: This segment has reported a decline in premium written since 2016. Though the same witnessed a reversal in 2018 with premium written up by 4%, the profitability of the segment, as measured by underwriting income, amounted to a loss of $3.1 billion (down from underwriting loss of $4.5 billion in 2017). Notably, the results show that a number of growth initiatives (reinsurance deal with Validus, cost control efforts, acquisition of Glatfelter, hiring industry leaders in key positions and others) undertaken are beginning to yield, the positive effect of the same in the underwriting results are still awaited.

Low Net Investment Income: In 2018, the company’s net investment income declined due to lower returns, primarily caused by lower hedge fund performance and decline in income from fixed maturity securities. In 2019, we expect net investment to be under pressure due to dovish stance of Fed, which is unlikely to see any interest rate hike in the same year. This will keep investment yields at low levels and constrain net investment income.

High Debt Level: The company’s debt is rising consistently since 2015. Its debt to equity ratio of 60% is higher than the industry’s average of 32%. Moreover, times interest earned ratio has declined to 1.2 from 2.3 in 2017. A fall in the same signifies reduced ability to serve on interest payments.

Decline in Profitability: The most important measure of a company’s profitability, ROE, has declined to 2.1% in 2018 from 4.1% in 2017. This is lower compared with the industry’s ROE of 8.1%, which also signifies the company’s operating inefficiency.

American International carries a Zacks Rank #5 (Strong Sell). The stock carries an Earnings ESP of -9.93%. We caution against stocks with a Zacks Ranks #4 or 5 (Strong Sell) going into the earnings announcement, especially when the company is witnessing negative estimate revisions.

A better ranked stock in the same space is Argo Group International Holdings, Inc. (NYSE:ARGO) , with a Zacks Rank #2 (Buy). The stock has surpassed earnings estimates in each of the four quarters with an average positive surprise of 225.1%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Prudential Financial, Inc. (PRU): Free Stock Analysis Report

American International Group, Inc. (AIG): Free Stock Analysis Report

The Progressive Corporation (PGR): Free Stock Analysis Report

Argo Group International Holdings, Ltd. (ARGO): Free Stock Analysis Report

Original post

Zacks Investment Research
AIG Stock Up 14% This Year, Are Its Troubles Over?

Related Articles

Declan Fallon
Indices Attempt Support Rally By Declan Fallon - Sep 17, 2021

Markets aren't exactly powering higher but there is an attempt to develop some form of swing low. The NASDAQ has the clearest opportunity. The last couple of 'white' candlesticks...

AIG Stock Up 14% This Year, Are Its Troubles Over?

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at’s discretion.

Write your thoughts here
Are you sure you want to delete this chart?
Post also to:
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email